You are here

Research

Eli Lilly reports first, promising results for an antibody against COVID-19

Today brings the first whisper of success for a class of closely watched drugs that it’s hoped will begin to beat back COVID-19 before vaccines are licensed: monoclonal antibodies, engineered versions of the same virus-fighting antibodies that the body naturally produces.

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

ANALYSIS: Why a vaccine will not stop the Covid-19 pandemic right away

...   while vaccine manufacturers, public health experts and the federal government are all confident one or more of the coronavirus vaccines being tested now will be shown to work safely by the end of the year, the US and the world will still be a long way from ending the pandemic. 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Anti-inflammatory drug may shorten Covid-19 recovery time, ELI Lilly says .

A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalized Covid-19 patients shortens their time to recovery by an additional day.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Research
howdy folks